Demonstration of ameliorating effect of vardenafil through its anti-inflammatory and neuroprotective properties in autism spectrum disorder induced by propionic acid on rat model

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. A. American Psychiatric and D.S.M.T.F. American Psychiatric Association, editors. Arlington (VA): American Psychiatric Association; 2013.
   Google Scholar
• Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism spectrum disorder among children aged 8 years – autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ. 2018;67(6):1–23.
   PubMed Web of Science ®Google Scholar
• Fernandez BA, Scherer SW. Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach. Dialogues Clin Neurosci. 2017;19(4):353–371.
   PubMed Web of Science ®Google Scholar
• Persico AM, Napolioni V. Autism genetics. Behav Brain Res. 2013;251:95–112.
   PubMed Web of Science ®Google Scholar
• Johnson NL, Giarelli E, Lewis C, et al. Genomics and autism spectrum disorder. J Nurs Scholarsh. 2013;45(1):69–78.
   PubMed Web of Science ®Google Scholar
• Akintunde ME, Rose M, Krakowiak P, et al. Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma. J Neuroimmunol. 2015;286:33–41.
   PubMed Web of Science ®Google Scholar
• Ashwood P, Krakowiak P, Hertz-Picciotto I, et al. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol. 2011;232(1-2):196–199.
   PubMed Web of Science ®Google Scholar
• Fernández de Cossío L, Guzmán A, van der Veldt S, et al. Prenatal infection leads to ASD-like behavior and altered synaptic pruning in the mouse offspring. Brain Behav Immun. 2017;63:88–98.
   PubMed Web of Science ®Google Scholar
• Saghazadeh A, Ataeinia B, Keynejad K, et al. A meta-analysis of pro-inflammatory cytokines in autism spectrum disorders: effects of age, gender, and latitude. J Psychiatr Res. 2019;115:90–102.
   PubMed Web of Science ®Google Scholar
• Al-Ayadhi LY, Mostafa GA. A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children. J Neuroinflammation. 2012;9(1):54.
   PubMedGoogle Scholar
• Suzuki K, Matsuzaki H, Iwata K, et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One. 2011;6(5):e20470.
   PubMed Web of Science ®Google Scholar
• Ornoy A, Weinstein-Fudim L, Ergaz Z. Prevention or amelioration of autism-like symptoms in animal models: will it bring us closer to treating human ASD? Int J Mol Sci. 2019;20(5):1074.
   Web of Science ®Google Scholar
• Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17(3):290–314.
   PubMed Web of Science ®Google Scholar
• Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am. 1992;266(5):68–74-7.
   PubMed Web of Science ®Google Scholar
• van Horssen J, van Schaik P, Witte M. Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders? Neurosci Lett. 2019;710:132931.
   PubMed Web of Science ®Google Scholar
• Gu F, Chauhan V, Kaur K, et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry. 2013;3(9):e299.
   PubMedGoogle Scholar
• Bronzuoli MR, Facchinetti R, Ingrassia D, et al. Neuroglia in the autistic brain: evidence from a preclinical model. Mol Autism. 2018;9(1):66.
   PubMedGoogle Scholar
• Dichter GS, Felder JN, Green SR, et al. Reward circuitry function in autism spectrum disorders. Soc Cogn Affect Neurosci. 2012;7(2):160–172.
   PubMed Web of Science ®Google Scholar
• Donovan AP, Basson MA. The neuroanatomy of autism – a developmental perspective. J Anat. 2017;230(1):4–15.
   PubMed Web of Science ®Google Scholar
• Bollen E, Prickaerts J. Phosphodiesterases in neurodegenerative disorders. IUBMB Life. 2012;64(12):965–970.
   PubMed Web of Science ®Google Scholar
• Miwa H, Kobayashi K, Hirai S, et al. GAD67-mediated GABA synthesis and signaling impinges on directing basket cell axonal projections toward Purkinje cells in the cerebellum. Cerebellum. 2021.
   PubMed Web of Science ®Google Scholar
• Hartell NA. Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression. J Neurosci. 1996;16(9):2881–2890.
   PubMed Web of Science ®Google Scholar
• Weber AM, Egelhoff JC, McKellop JM, et al. Autism and the cerebellum: evidence from tuberous sclerosis. J Autism Dev Disord. 2000;30(6):511–517.
   PubMed Web of Science ®Google Scholar
• Hegde S, Capell WR, Ibrahim BA, et al. Phosphodiesterase 11A (PDE11A), enriched in ventral hippocampus neurons, is required for consolidation of social but not nonsocial memories in mice. Neuropsychopharmacology. 2016;41(12):2920–2931.
   PubMed Web of Science ®Google Scholar
• Al-Lahham SH, Peppelenbosch MP, Roelofsen H, et al. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010;1801(11):1175–1183.
   PubMed Web of Science ®Google Scholar
• El-Ansary AK, Bacha AB, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation. 2012;9(1):74.
   PubMedGoogle Scholar
• DeCastro M, Nankova BB, Shah P, et al. Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Brain Res Mol Brain Res. 2005;142(1):28–38.
   PubMedGoogle Scholar
• Wajner M, Latini A, Wyse ATS, et al. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis. 2004;27(4):427–448.
   PubMed Web of Science ®Google Scholar
• Hara H, Haga S, Aoyama Y, et al. Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr. 1999;129(5):942–948.
   PubMed Web of Science ®Google Scholar
• Thomas RH, Meeking MM, Mepham JR, et al. The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation. 2012;9:153.
   PubMed Web of Science ®Google Scholar
• Solmaz V, Tekatas A, Erdoğan MA, et al. Exenatide, a GLP-1 analog, has healing effects on LPS-induced autism model: inflammation, oxidative stress, gliosis, cerebral GABA, and serotonin interactions. Int J Dev Neurosci. 2020;80(7):601–612.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Bingmann D, Wiemann M. Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones. Eur Neuropsychopharmacol. 2000;10(2):97–103.
   PubMed Web of Science ®Google Scholar
• Abdelli LS, Samsam A, Naser SA. Propionic acid induces gliosis and neuro-inflammation through modulation of PTEN/AKT pathway in autism spectrum disorder. Sci Rep. 2019;9:1–12.
   PubMed Web of Science ®Google Scholar
• Kamen CL, Zevy DL, Ward JM, et al. Systemic treatment with the enteric bacterial fermentation product, propionic acid, reduces acoustic startle response magnitude in rats in a dose-dependent fashion: contribution to a rodent model of ASD. Neurotox Res. 2019;35(2):353–359.
   PubMed Web of Science ®Google Scholar
• Mehan S, Rahi S, Tiwari A, et al. Adenylate cyclase activator forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats. Neural Regen Res. 2020;15(6):1140–1149.
   PubMed Web of Science ®Google Scholar
• Sharma R, Rahi S, Mehan S. Neuroprotective potential of solanesol in intracerebroventricular propionic acid induced experimental model of autism: insights from behavioral and biochemical evidence. Toxicol Rep. 2019;6:1164–1175.
   PubMed Web of Science ®Google Scholar
• Salonia A, Bettocchi C, Boeri L, et al. European association of urology guidelines on sexual and reproductive health-2021 update: male sexual dysfunction. Eur Urol. 2021;80(3):333–357.
   PubMed Web of Science ®Google Scholar
• Prickaerts J, Sik A, van Staveren WCG, et al. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int. 2004;45(6):915–928.
   PubMed Web of Science ®Google Scholar
• Reneerkens OAH, Rutten K, Akkerman S, et al. Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for Central and peripheral mechanisms. Neurobiol Learn Mem. 2012;97(4):370–379.
   PubMed Web of Science ®Google Scholar
• Peixoto CA, Nunes AKS, Garcia-Osta A. Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition. Mediators Inflamm. 2015;2015:940207.
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang Y, Zhang L, et al. Sildenafil (viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke. 2002;33(11):2675–2680.
   PubMed Web of Science ®Google Scholar
• Prickaerts J, van Staveren WCG, Sik A, et al. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience. 2002;113(2):351–361.
   PubMed Web of Science ®Google Scholar
• Devan BD, Bowker JL, Duffy KB, et al. Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology (Berl). 2006;183(4):439–445.
   PubMed Web of Science ®Google Scholar
• Erbas O, Erdogan MA, Khalilnezhad A, et al. Neurobehavioral effects of long-term maternal fructose intake in rat offspring. Int J Dev Neurosci. 2018;69:68–79.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Cecil KM. Proton magnetic resonance spectroscopy: technique for the neuroradiologist. Neuroimaging Clin N Am. 2013;23(3):381–392.
   PubMed Web of Science ®Google Scholar
• Chugani DC, Sundram BS, Behen M, et al. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23(4):635–641.
   PubMed Web of Science ®Google Scholar
• Friedman SD, Shaw DW, Artru AA, et al. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology. 2003;60(1):100–107.
   PubMed Web of Science ®Google Scholar
• Corrigan NM, Shaw DWW, Richards TL, et al. Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J Autism Dev Disord. 2012;42(1):105–115.
   PubMed Web of Science ®Google Scholar
• Goh S, Dong Z, Zhang Y, et al. Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. JAMA Psychiatry. 2014;71(6):665–671.
   PubMed Web of Science ®Google Scholar
• Nickl-Jockschat T, Michel TM. The role of neurotrophic factors in autism. Mol Psychiatry. 2011;16(5):478–490.
   PubMed Web of Science ®Google Scholar
• Vahia VN. Diagnostic and statistical manual of mental disorders 5: a quick glance. Indian J Psychiatry. 2013;55(3):220–223.
   PubMed Web of Science ®Google Scholar
• Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D. Endocannabinod signal dysregulation in autism spectrum disorders: a correlation link between inflammatory state and neuro-immune alterations. Int J Mol Sci. 2017;18(7).
   Web of Science ®Google Scholar
• Erten F. Lycopene ameliorates propionic acid-induced autism spectrum disorders by inhibiting inflammation and oxidative stress in rats. J Food Biochem. 2021;45(10):e13922.
   PubMed Web of Science ®Google Scholar
• Meltzer A, Van de Water J. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology. 2017;42(1):284–298.
   PubMed Web of Science ®Google Scholar
• Al-Dbass AM. N-Acetylcysteine reduces the neurotoxic effects of propionic acid in rat pups. J King Saud Univ Sci. 2014;26(4):254–260.
   Google Scholar
• Mirza R, Sharma B. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress. Chem Biol Interact. 2019;311:108758.
   PubMed Web of Science ®Google Scholar
• MacFabe DF, Cain DP, Rodriguez-Capote K, et al. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res. 2007;176(1):149–169.
   PubMed Web of Science ®Google Scholar
• Milovanovic J, Arsenijevic A, Stojanovic B, et al. Interleukin-17 in chronic inflammatory neurological diseases. Front Immunol. 2020;11:947–947.
   PubMed Web of Science ®Google Scholar
• Kirsten TB, Casarin RC, Bernardi MM, et al. Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. PLoS One. 2018;13(5):e0197060.
   PubMed Web of Science ®Google Scholar
• Choi GB, Yim YS, Wong H, et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016;351(6276):933–939.
   PubMed Web of Science ®Google Scholar
• Solmaz V, Erdoğan MA, Alnak A, et al. Erythropoietin shows gender dependent positive effects on social deficits, learning/memory impairments, neuronal loss and neuroinflammation in the lipopolysaccharide induced rat model of autism. Neuropeptides. 2020;83:102073.
   PubMed Web of Science ®Google Scholar
• Singh VK, Warren RP, Odell JD, et al. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin Immunol Immunopathol. 1991;61(3):448–455.
   PubMedGoogle Scholar
• Gurney ME, Cogram P, Deacon RM, et al. Multiple behavior phenotypes of the Fragile-X syndrome mouse model respond to chronic inhibition of phosphodiesterase-4D (PDE4D). Sci Rep. 2017;7(1):14653–14653.
   PubMedGoogle Scholar
• Kayık G, Tüzün N, Durdagi S. Investigation of PDE5/PDE6 and PDE5/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development. J Enzyme Inhib Med Chem. 2017;32(1):311–330.
   PubMed Web of Science ®Google Scholar
• László A, Horváth E, Eck E, et al. Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin Chim Acta. 1994;229(1-2):205–207.
   PubMed Web of Science ®Google Scholar
• Weissman JR, Kelley RI, Bauman ML, et al. Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One. 2008;3(11):e3815.
   PubMed Web of Science ®Google Scholar
• Vallée A, Vallée J-N. Warburg effect hypothesis in autism spectrum disorders. Mol Brain. 2018;11(1):1.
   PubMedGoogle Scholar
• Hagihara H, Catts VS, Katayama Y, et al. Decreased brain pH as a shared endophenotype of psychiatric disorders. Neuropsychopharmacology. 2018;43(3):459–468.
   PubMed Web of Science ®Google Scholar
• Shepherd GM. Corticostriatal connectivity and its role in disease. Nat Rev Neurosci. 2013;14(4):278–291.
   PubMed Web of Science ®Google Scholar
• Prince JA, Blennow K, Gottfries CG, et al. Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology. 1999;21(3):372–379.
   PubMed Web of Science ®Google Scholar
• Graybiel AM. The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem. 1998;70(1-2):119–136.
   PubMed Web of Science ®Google Scholar
• Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008;31(3):137–145.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Aldinger KA, Ashwood P, et al. Consensus paper: pathological role of the cerebellum in autism. Cerebellum. 2012;11(3):777–807.
   PubMed Web of Science ®Google Scholar
• Ito M. Mechanisms of motor learning in the cerebellum. Brain Res. 2000;886(1-2):237–245.
   PubMed Web of Science ®Google Scholar
• Giuili G, Luzi A, Poyard M, et al. Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny. Brain Res Dev Brain Res. 1994;81(2):269–283.
   PubMedGoogle Scholar
• Juilfs DM, Soderling S, Burns F, et al. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Rev Physiol Biochem Pharmacol. 1999;135:67–104.
   PubMedGoogle Scholar
• Dinçel N, Ünalp A, Kutlu A, Öztürk A, Uran N, Ulusoy S. Serum nerve growth factor levels in autistic children in Turkish population: a preliminary study. Indian J Med Res. 2013;138(6):900–903.
   PubMedGoogle Scholar
• Choi J, Lee S, Won J, et al. Pathophysiological and neurobehavioral characteristics of a propionic acid-mediated autism-like rat model. PLoS One. 2018;13(2):e0192925.
   PubMed Web of Science ®Google Scholar
• González-Cano SI, Camacho-Abrego I, Diaz A, et al. Prenatal exposure to propionic acid induces altered locomotion and reactive astrogliosis in male rats. J Chem Neuroanat. 2021;117:102011.
   PubMed Web of Science ®Google Scholar
• MacFabe DF, Cain NE, Boon F, et al. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res. 2011;217(1):47–54.
   PubMed Web of Science ®Google Scholar
• Wegiel J, Flory M, Kuchna I, et al. Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum. Acta Neuropathol Commun. 2014;2(1):141.
   PubMedGoogle Scholar
• Puzzo D, Staniszewski A, Deng SX, et al. Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer’s disease mouse model. J Neurosci. 2009;29(25):8075–8086.
   PubMed Web of Science ®Google Scholar
• Cuadrado-Tejedor M, Hervias I, Ricobaraza A, et al. Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer’s disease. Br J Pharmacol. 2011;164(8):2029–2041.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guo J, Zhao X, et al. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behav Brain Res. 2013;250:230–237.
   PubMed Web of Science ®Google Scholar
• Doggrell SA. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opin Pharmacother. 2005;6(1):75–84.
   PubMed Web of Science ®Google Scholar
• Kumada T, Lakshmana MK, Komuro H. Reversal of neuronal migration in a mouse model of fetal alcohol syndrome by controlling second-messenger signalings. J Neurosci. 2006;26(3):742–756.
   PubMed Web of Science ®Google Scholar
• Carlezon WA, Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 2005;28(8):436–445.
   PubMed Web of Science ®Google Scholar
• Maurice DH, Ke H, Ahmad F, et al. Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov. 2014;13(4):290–314.
   PubMed Web of Science ®Google Scholar
• Handa P, Tateya S, Rizzo NO, et al. Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol. 2011;31(12):2827–2835.
   PubMed Web of Science ®Google Scholar
• Peixoto C, Nunes AK, Rapôso C. The role of NO/cGMP signaling on neuroinflammation: a new therapeutic opportunity. In Abreu GEA, editor. Mechanisms ofNeuroinflammation. London: IntechOpen; 2017. p. 167–208.
   Google Scholar
• Matthews JR, Botting CH, Panico M, et al. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 1996;24(12):2236–2242.
   PubMed Web of Science ®Google Scholar